Big Pharma Split Corp.
PRM.TO · TSX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -CA$539 | -CA$645 | CA$2,389 | CA$4,210 |
| Dep. & Amort. | CA$0 | CA$0 | CA$0 | CA$0 |
| Deferred Tax | CA$0 | CA$0 | CA$0 | CA$0 |
| Stock-Based Comp. | CA$0 | CA$0 | CA$0 | CA$0 |
| Change in WC | -CA$12 | CA$10 | CA$175 | -CA$154 |
| Other Non-Cash | -CA$744 | CA$12,494 | -CA$1,436 | -CA$13,056 |
| Operating Cash Flow | -CA$1,296 | CA$11,858 | CA$1,128 | -CA$9,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | CA$0 | -CA$0 | CA$0 | CA$0 |
| Net Acquisitions | CA$0 | CA$0 | CA$0 | CA$0 |
| Inv. Purchases | CA$0 | CA$0 | CA$0 | CA$0 |
| Inv. Sales/Matur. | CA$0 | CA$0 | CA$0 | CA$0 |
| Other Inv. Act. | CA$0 | CA$0 | CA$0 | CA$0 |
| Investing Cash Flow | CA$0 | CA$0 | CA$0 | CA$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | CA$1,284 | -CA$5,485 | CA$481 | CA$5,747 |
| Stock Issued | CA$343 | CA$0 | CA$400 | CA$7,574 |
| Stock Repurch. | -CA$469 | -CA$5,322 | CA$0 | CA$0 |
| Dividends Paid | -CA$1,504 | -CA$2,109 | -CA$2,616 | -CA$2,836 |
| Other Fin. Act. | CA$0 | -CA$4,595 | CA$481 | CA$5,747 |
| Financing Cash Flow | -CA$346 | -CA$12,471 | -CA$1,737 | CA$10,194 |
| Forex Effect | CA$2,468 | -CA$3 | -CA$2 | CA$5 |
| Net Chg. in Cash | CA$826 | -CA$615 | -CA$611 | CA$1,199 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | CA$204 | CA$819 | CA$1,430 | CA$231 |
| End Cash | CA$1,031 | CA$204 | CA$819 | CA$1,430 |
| Free Cash Flow | -CA$1,296 | CA$11,858 | CA$1,128 | -CA$9,000 |